Product Information

METHIMAZOLE 5 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.0706 per EA under NDC 72578021201. Its NADAC has been published 56 times since Oct 29, 2025.

FDA first approved this application on Feb 5, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHIMAZOLE 5 MG TABLET

methimazole
$0.0706per EA

Strength

5 mg/1

NDC

72578021201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHIMAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA218830

FDA Approved

2/5/2025

TE Code

AB

On Market Since

9/10/2025

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for METHIMAZOLE 5 MG TABLET has been published 56 times since Oct 29, 2025, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0706 per EA
All-time high$0.0830 (Nov 12, 2025)
All-time low$0.0694 (Oct 21, 2026)
52-week high$0.0788
52-week low$0.0694
Median price$0.0722
Average price$0.0734
Largest weekly change-5.0% (Nov 19, 2025)
Weeks tracked56
Tracking sinceOct 29, 2025

Price History

1W

+1.7%

1M

+0.5%

3M

-0.2%

6M

-2.0%

1Y

-15.0%

3Y

N/A

5Y

N/A

All

-15.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHIMAZOLE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.0706 per EA (NDC 72578021201), effective Nov 18, 2026.

How has the price of METHIMAZOLE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has declined 15.0%. It has been tracked across 56 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?

Since Oct 29, 2025, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0694 (Oct 21, 2026) to a high of $0.0830 (Nov 12, 2025), with a median of $0.0722 per EA.

Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHIMAZOLE 5 MG TABLET?

METHIMAZOLE 5 MG TABLET (NDC 72578021201) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.